SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD. Suzhou Fushilai Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 156.49 million compared to CNY 141.78 million a year ago. Revenue was CNY 156.49 million compared to CNY 141.78 million a year ago.
Net income was CNY 51.61 million compared to CNY 39.92 million a year ago. Basic earnings per share from continuing operations was CNY 0.56 compared to CNY 0.58 a year ago. Diluted earnings per share from continuing operations was CNY 0.56 compared to CNY 0.58 a year ago.
